Immunocore Holdings (IMCR) Tax Provisions (2023 - 2026)

Immunocore Holdings has disclosed Tax Provisions across 4 years of filings, most recently posting $300000.0 for Q1 2026.

• Tax Provisions for Q1 2026 came in at $300000.0, down 72.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.7 million (up 1594.76% YoY), and the FY2025 annual result was $16.4 million, up 987.24% from the prior year.
• Tax Provisions came in at $300000.0 for Q1 2026 at Immunocore Holdings, down from $14.3 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $14.3 million in Q4 2025 to a low of -$5.9 million in Q4 2023.
• The 4-year median for Tax Provisions is $300000.0 (2026), against an average of $723076.9.
• Across the five-year window, Tax Provisions sank 1385.71% in 2024 and jumped 1463.24% in 2025, its largest moves.
• Immunocore Holdings' Tax Provisions stood at -$5.9 million in 2023, then soared by 82.24% to -$1.0 million in 2024, then surged by 1463.24% to $14.3 million in 2025, then plunged by 97.9% to $300000.0 in 2026.
• The last three Tax Provisions figures came in at $300000.0 (Q1 2026), $14.3 million (Q4 2025), and $481000.0 (Q3 2025), per Business Quant data.